What should be done if a patient experiences an allergic reaction to Pepsi?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Allergic Reaction to Pepsi

Patients experiencing an allergic reaction to Pepsi should receive immediate intramuscular epinephrine as first-line treatment, followed by observation for 4-6 hours and referral to an allergist for comprehensive evaluation and management. 1, 2

Initial Management

Immediate Treatment

  1. Administer epinephrine intramuscularly:

    • Adults and children ≥30 kg: 0.3-0.5 mg (0.3-0.5 mL of 1:1000 solution) into anterolateral thigh 2, 3
    • Children <30 kg: 0.01 mg/kg (0.01 mL/kg), maximum 0.3 mg per injection 3
    • May repeat every 5-15 minutes as needed 2, 3
  2. Airway and breathing support:

    • Administer 100% oxygen if respiratory symptoms are present
    • Position patient appropriately (recumbent with legs elevated if hypotensive) 2
    • For bronchospasm: albuterol via MDI or nebulizer 2
  3. Circulatory support:

    • IV fluid resuscitation: 10-20 mL/kg rapid infusion for hypotension 2
    • For refractory hypotension: additional epinephrine, vasopressors, or glucagon (especially for patients on beta-blockers) 2

Adjunctive Treatments

After epinephrine administration, consider:

  • H1 antihistamine: diphenhydramine 1-2 mg/kg (max 50 mg) every 6 hours for 2-3 days 1, 2
  • H2 antihistamine: ranitidine 1-2 mg/kg (max 75-150 mg) twice daily for 2-3 days 1, 2
  • Corticosteroid: prednisone 1 mg/kg (max 60-80 mg) daily for 2-3 days 1, 2

Observation Period

  • Monitor for 4-6 hours after successful treatment 1, 2
  • Extended observation (8-24 hours) for patients with:
    • Severe initial reactions
    • History of biphasic reactions
    • Significant comorbidities 2, 4

Discharge Plan

All patients who have experienced anaphylaxis should be sent home with:

  1. Epinephrine auto-injector prescription:

    • Prescribe 2 doses 1
    • Provide training on proper use 1, 2
    • Advise on checking expiration dates and proper storage 1
  2. Written anaphylaxis emergency action plan 1, 2

  3. Patient education on:

    • Allergen avoidance (specifically Pepsi and potentially related products)
    • Recognition of anaphylaxis symptoms
    • When to use epinephrine and seek emergency care 1, 2
  4. Medical identification jewelry or anaphylaxis wallet card 1, 2

  5. Follow-up appointments:

    • Primary care provider within 1-2 weeks 1
    • Referral to allergist/immunologist for comprehensive evaluation 1, 2, 4

Special Considerations

High-Risk Patients

Patients with the following conditions require extra vigilance:

  • Asthma
  • Mast cell disorders
  • Cardiovascular disease
  • Those taking beta-blockers or ACE inhibitors 2, 4

Potential Allergens in Pepsi

  • The allergic reaction may be due to ingredients in Pepsi such as:
    • Caramel coloring
    • Preservatives
    • Flavorings
    • Other additives 5

Biphasic Reactions

  • Can occur up to 72 hours after initial reaction 2
  • More common in severe reactions or those with delayed epinephrine administration 4

Allergist Referral Importance

The allergist will:

  • Identify the specific allergen in Pepsi causing the reaction
  • Perform appropriate testing (skin tests, serum specific IgE)
  • Provide guidance on cross-reactive substances to avoid
  • Consider immunotherapy if appropriate 1, 4

Remember that anaphylaxis is a life-threatening emergency, and prompt recognition and treatment with epinephrine is essential for reducing morbidity and mortality 2, 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Anaphylaxis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Anaphylaxis: Recognition and Management.

American family physician, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.